Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Kenji Imajo"'
Autor:
Kenta Hayashino, Chikamasa Yoshida, Yoshiyuki Ayata, Ryouya Yukawa, Aya Komura, Makoto Nakamura, Yusuke Meguri, Kazuhiko Yamamoto, Wakako Oda, Kenji Imajo
Publikováno v:
Journal of Clinical & Experimental Hematopathology; 2024, Vol. 64 Issue 1, p52-58, 7p
Autor:
Kenta Hayashino, Yusuke Meguri, Ryouya Yukawa, Aya Komura, Makoto Nakamura, Chikamasa Yoshida, Kazuhiko Yamamoto, Wakako Oda, Kenji Imajo
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 17, p2531-2537, 7p
Autor:
Kenta Hayashino, Yusuke Meguri, Ryouya Yukawa, Aya Komura, Makoto Nakamura, Chikamasa Yoshida, Kazuhiko Yamamoto, Wakako Oda, Kenji Imajo
Publikováno v:
International journal of hematology. 117(1)
Primary effusion lymphoma-like lymphoma (PEL-LL) shows a unique clinical presentation, characterized by lymphomatous effusions in the body cavities. PEL-LL may be associated with hepatitis C virus infections and fluid overload states; and owing to it
Autor:
Kenji Imajo, Akiko Kumagai, Kazunori Imada, Kensuke Usuki, Shinji Nakao, Naoshi Obara, Tetsuo Maeda, Takeshi Tajima, Hiroatsu Iida, Akira Matsuda, Zhang Fanghong, Yosuke Hombo
Publikováno v:
Internal Medicine
Objective In Japan, immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG), and cyclosporine A (CsA) is the standard of care in patients with aplastic anemia (AA) who are not indicated for stem-cell transplantation, although some patients
Autor:
Nobuharu Fujii, Yoshinobu Maeda, Hisakazu Nishimori, Masanori Makita, Yasuharu Sato, Daisuke Ennishi, Yuka Sogabe, Yusuke Yoshimoto, Koh Ichi Ohshima, Yusuke Meguri, Ken-ichi Matsuoka, Yuichi Sumii, Tadashi Yoshino, Noboru Asada, Kenji Imajo
Publikováno v:
International Journal of Hematology. 112:780-786
IgG4-producing marginal zone B-cell lymphomas (MZLs) have been recently proposed as a subtype of MZLs. Despite the abundant literature on pathophysiological features of this type of lymphoma, only a few retrospective studies pertaining to the treatme
[Aseptic meningitis as paraneoplastic syndrome related to chronic myeloid leukemia in chronic phase]
Autor:
Yusuke, Meguri, Kentaro, Deguchi, Tomohito, Kawano, Kenta, Hayashino, Aya, Komura, Yutaro, Shiraishi, Chikamasa, Yoshida, Shoko, Nagotani, Kazuhiko, Yamamoto, Kenji, Imajo
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(11)
Chronic myeloid leukemia (CML) is a clonal hemopoietic stem cell disorder characterized by reciprocal translocation between the long arms of chromosomes 9 and 22 that produces the fusion BCR-ABL1 gene. Major manifestations in CML patients are increas
Autor:
Akira Matsuda, Kazunori Imada, Naoshi Obara, Hiroatsu Iida, Hirohito Yamazaki, Yoshiaki Tomiyama, Koichi Miyamura, Osamu Sasaki, Tetsuo Maeda, Kensuke Ohta, Kensuke Usuki, Yukihiro Tokumine, Kenji Imajo, Yuji Okamoto, Mami Murakami, Shinji Nakao
Publikováno v:
American journal of clinical pathology. 158(5)
Objectives Eltrombopag, a thrombopoietin-receptor agonist, stimulates hematopoiesis in patients with acquired aplastic anemia (AA). Cytomorphologic changes in bone marrow after eltrombopag administration are still unclear. This study examined the eff
Autor:
Chikamasa Yoshida, Kenji Imajo, Chisato Matsubara, Yusuke Meguri, Kenta Hayashino, Kazuhiko Yamamoto, Aya Komura, Yutarou Shiraishi
Publikováno v:
Internal medicine (Tokyo, Japan). 61(11)
Scurvy is a rare disease caused by a vitamin C deficiency. Vitamin C is a water-soluble vitamin found in vegetables and fruits, but it is lost after boiling. A 59-year-old man presented with gingival pain after having a tooth extracted five years pre
Autor:
Nobuharu Kosugi, Yasuhiro Maeda, Yuichiro Nawa, Hiroyuki Kuroda, Hajime Kobayashi, Koiti Inokuchi, Chikashi Yoshida, Takashi Kumagai, Takafumi Nakao, Masato Shikami, Eisei Kondo, Kenji Imajo, Takeshi Kondo, Hiroshi Kosugi, Satoshi Morita, Sho Komukai, Atsushi Kawaguchi, Yoshinobu Maeda, Noriko Doki, Kensuke Kojima, Hiroshi Harada, Yoko Tabe, Akio Saito, Junji Nishida, Masahiro Ogasawara, Kensuke Usuki, Shin Fujisawa, Yoshinobu Kanda, Shinya Kimura, Junichi Sakamoto, Toru Sakura, Yasunori Ueda
Publikováno v:
International Journal of Clinical Oncology
Background Treatment-free remission (TFR), the ability to maintain a molecular response (MR), occurs in approximately 50% of patients with chronic myelogenous leukemia (CML) treated with tyrosine kinase inhibitors (TKIs). Methods A multicenter phase
Autor:
Kenta Hayashino, Yusuke Meguri, Aya Komura, Chisato Matsubara, Yutarou Shiraishi, Chikamasa Yoshida, Kazuhiko Yamamoto, Kenji Imajo
Publikováno v:
Internal Medicine; 2022, Vol. 61 Issue 11, p1795-1798, 4p